Precision Medicine Software Market to Accelerate Growth via AI and Multi-Omics Integration
Precision Medicine Software Market Size, Share & Growth Report by
Summary
The global precision medicine software market is projected to grow from USD 2.26 billion in 2025 to USD 6.10 billion by 2034, with a CAGR of 11.67%. This growth is driven by the expansion of AI-powered clinical decision support tools and the shift toward multi-omics integration combining various data types like genomics and proteomics.
Details
The precision medicine software market encompasses digital platforms designed to collect, process, and interpret genomic, clinical, and molecular data for personalized healthcare decisions. The projected growth is fueled by the surge in pharmacogenomic-based prescribing. Key technological trends include the dominance of AI/machine learning models and generative AI. Furthermore, the industry is moving toward multi-omics integration—combining genomics, proteomics, metabolomics, and transcriptomics—to capture complex biological interactions. From a data architecture standpoint, there is a shift from centralized systems to federated learning frameworks, which allows collaborative analysis across multiple institutions while maintaining patient privacy. The software serves diverse end users, including hospitals, pharmaceutical companies, and diagnostic laboratories globally. Interoperability standards like FHIR/HL7 are crucial for enhancing the precision of analysis across different clinical workflows. While North America currently holds a dominant market share, the Asia Pacific region is expected to be the fastest-growing area.
Technology Note
FHIR（Fast Healthcare Interoperability Resources）は医療データ交換の国際標準。このエントリの関連技術: HL7
Original content copyright by respective publishers